查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1591868

荷爾蒙避孕藥市場：按荷爾蒙、避孕方法和最終用戶分類 - 全球預測 2025-2030

Hormonal Contraceptives Market by Hormone (Androgens, Antiandrogens, Estrogens), Method (Combined Oral Contraceptives, Implanted Contraceptives, Injected Contraceptives), End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年荷爾蒙避孕藥市值為171.9億美元，預計到2024年將達到183.4億美元，複合年成長率為6.76%，到2030年將達到271.9億美元。

荷爾蒙避孕藥的市場範圍包括透過調節女性體內荷爾蒙水平來預防懷孕的各種方法。這包括口服藥、注射、貼片、避孕環、植入等。雖然荷爾蒙避孕藥主要用於避孕，但它們也有調節月經週期、控制卵巢症候群 (PCOS) 等疾病和減少痤瘡等益處。最終用途涵蓋私人消費者和醫療機構。市場成長的推動因素包括計劃生育意識的提高、月經相關疾病盛行率的上升以及對現代避孕方法的接受程度的提高。新的商機存在於避孕教育和服務需求未滿足的領域，以及開發可最大限度減少副作用的先進分娩系統。專注於非侵入性避孕藥和長效避孕藥等創新的公司有潛力佔領重要的市場佔有率。然而，挑戰包括文化和宗教的反對、持續使用的需要、與荷爾蒙方法相關的副作用以及來自非荷爾蒙替代品的競爭。監管障礙也會推遲產品發布並影響市場動態。限制因素包括低收入地區的價格敏感度以及影響可用性和核准的國家政策差異。個人化醫療和基因分析等技術進步提供了創新途徑，透過最佳化荷爾蒙劑量實現有針對性的避孕解決方案，從而提高療效並減少副作用。市場可以從對人口趨勢、消費行為和客製化行銷策略的洞察中受益。荷爾蒙避孕市場的競爭性和不斷發展的性質要求公司能夠對不斷變化的消費者偏好和科學開拓做出快速反應。在負擔能力、可及性和關於荷爾蒙避孕的優點和缺點的全面教育宣傳活動之間保持平衡對於永續成長至關重要。

主要市場統計
基準年[2023] 171.9億美元
預測年份 [2024] 183.4億美元
預測年份 [2030] 271.9億美元
複合年成長率（%） 6.76%

市場動態：揭示快速發展的荷爾蒙避孕藥市場的關鍵市場洞察

供需的動態交互作用正在改變荷爾蒙避孕市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 女性懷孕相關健康風險案例增加
    • 政府努力促進避孕藥具的使用
    • 線上提供口服避孕藥
  • 市場限制因素
    • 荷爾蒙避孕藥的副作用
  • 市場機會
    • 研究創造高效避孕方法
    • 改善荷爾蒙避孕藥的廣告和行銷
  • 市場問題
    • 社會對荷爾蒙避孕藥的接受度有限

波特的五力：駕馭荷爾蒙避孕市場的策略工具

波特的五力框架是了解荷爾蒙避孕藥市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解荷爾蒙避孕藥市場的外部影響

外部宏觀環境因素在塑造荷爾蒙避孕藥市場的表現動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解荷爾蒙避孕藥市場的競爭格局

對荷爾蒙避孕藥市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：荷爾蒙避孕藥市場供應商的績效評估

FPNV定位矩陣是評估荷爾蒙避孕藥市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製荷爾蒙避孕藥市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對荷爾蒙避孕藥市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 與懷孕相關的女性健康風險增加
      • 政府努力促進避孕器的使用
      • 在線購買口服避孕藥
    • 抑制因素
      • 荷爾蒙避孕藥的副作用
    • 機會
      • 研究開發高效避孕方法
      • 改善荷爾蒙避孕藥的廣告和行銷
    • 任務
      • 社會對荷爾蒙避孕藥的接受度有限
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章 荷爾蒙避孕藥市場：依荷爾蒙分類

  • 介紹
  • 雄激素
  • 抗雄激素
  • 雌激素
  • 促性腺激素分泌
  • 黃體素

第7章 荷爾蒙避孕藥市場：依避孕方法分類

  • 介紹
  • 複方口服避孕藥
  • 植入式避孕器
  • 注射避孕
  • 在子宮內
  • 口服避孕藥
  • 經皮吸收貼片
  • 避孕環

第8章荷爾蒙避孕藥市場：依最終用戶分類

  • 介紹
  • 門診手術中心
  • 婦科中心
  • 居家醫療
  • 醫院/診所

第9章美洲激素避孕藥市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區荷爾蒙避孕藥市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的荷爾蒙避孕市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Afaxys Pharma, LLC
  • Agile Therapeutics
  • Amgen Inc.
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Cipla Limited
  • Glenmark Pharmaceuticals Limited
  • HLL Lifecare Limited
  • Johnson & Johnson Services, Inc.
  • Lupin Pharmaceuticals, Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Piramal Group
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-4103B31E0668

The Hormonal Contraceptives Market was valued at USD 17.19 billion in 2023, expected to reach USD 18.34 billion in 2024, and is projected to grow at a CAGR of 6.76%, to USD 27.19 billion by 2030.

The scope of the market for hormonal contraceptives encompasses various methods to prevent pregnancy by modulating hormone levels in the female body. This includes oral pills, injections, patches, vaginal rings, and implants. The application of hormonal contraceptives primarily targets birth control, but also offers benefits such as regulating menstrual cycles, managing conditions like polycystic ovary syndrome (PCOS), and reducing acne. End-use scope spans across individual consumers and healthcare facilities. Market growth is fuelled by increasing awareness of family planning, rising prevalence of menstrual-related disorders, and growing acceptance of modern contraceptive methods. Emerging opportunities lie in regions with unmet needs for contraceptive education and services, as well as in developing advanced delivery systems that minimize side effects. Companies focusing on innovation, such as non-invasive contraceptives and those with extended duration of effectiveness, could capture significant market share. Meanwhile, challenges include cultural and religious opposition, the need for consistent usage, side effects associated with hormonal methods, and competition from non-hormonal alternatives. Regulatory hurdles can also delay product launches and affect market dynamics. Limiting factors might involve price sensitivity in low-income regions and varying national policies affecting availability and approval. Technological advancements like personalized medicine and genetic profiling offer avenues for innovation, enabling targeted contraceptive solutions with optimized hormonal dosages, thereby improving effectiveness and reducing side effects. The market can benefit from insights into demographic trends, consumer behavior, and tailored marketing strategies. The nature of the hormonal contraceptives market is competitive and fast-evolving, requiring businesses to adapt rapidly to changing consumer preferences and scientific developments. Maintaining a balance between affordability, accessibility, and comprehensive educational campaigns about the benefits and drawbacks of hormonal contraception is crucial for sustainable growth.

KEY MARKET STATISTICS
Base Year [2023] USD 17.19 billion
Estimated Year [2024] USD 18.34 billion
Forecast Year [2030] USD 27.19 billion
CAGR (%) 6.76%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Hormonal Contraceptives Market

The Hormonal Contraceptives Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing cases of pregnancy-related health risks in women
    • Government initiatives to promote the use of contraceptives
    • Availability of oral contraceptives online
  • Market Restraints
    • Side effects of hormonal contraceptives
  • Market Opportunities
    • Research studies for producing highly effective contraceptive methods
    • Improving advertisements and marketing of hormonal contraceptives
  • Market Challenges
    • Limited social acceptance of hormonal contraceptives

Porter's Five Forces: A Strategic Tool for Navigating the Hormonal Contraceptives Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Hormonal Contraceptives Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Hormonal Contraceptives Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Hormonal Contraceptives Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Hormonal Contraceptives Market

A detailed market share analysis in the Hormonal Contraceptives Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Hormonal Contraceptives Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Hormonal Contraceptives Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Hormonal Contraceptives Market

A strategic analysis of the Hormonal Contraceptives Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Hormonal Contraceptives Market, highlighting leading vendors and their innovative profiles. These include Afaxys Pharma, LLC, Agile Therapeutics, Amgen Inc., Bayer AG, Boehringer Ingelheim GmbH, Cipla Limited, Glenmark Pharmaceuticals Limited, HLL Lifecare Limited, Johnson & Johnson Services, Inc., Lupin Pharmaceuticals, Inc., Novartis AG, Pfizer, Inc., Piramal Group, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Hormonal Contraceptives Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Hormone, market is studied across Androgens, Antiandrogens, Estrogens, Gonadotropins, and Progestogens.
  • Based on Method, market is studied across Combined Oral Contraceptives, Implanted Contraceptives, Injected Contraceptives, Intrauterine, Oral Contraceptives, Transdermal Patch, and Vaginal Ring.
  • Based on End-user, market is studied across Ambulatory Surgical Centers, Gynecology Centers, Homecare, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cases of pregnancy-related health risks in women
      • 5.1.1.2. Government initiatives to promote the use of contraceptives
      • 5.1.1.3. Availability of oral contraceptives online
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects of hormonal contraceptives
    • 5.1.3. Opportunities
      • 5.1.3.1. Research studies for producing highly effective contraceptive methods
      • 5.1.3.2. Improving advertisements and marketing of hormonal contraceptives
    • 5.1.4. Challenges
      • 5.1.4.1. Limited social acceptance of hormonal contraceptives
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Hormonal Contraceptives Market, by Hormone

  • 6.1. Introduction
  • 6.2. Androgens
  • 6.3. Antiandrogens
  • 6.4. Estrogens
  • 6.5. Gonadotropins
  • 6.6. Progestogens

7. Hormonal Contraceptives Market, by Method

  • 7.1. Introduction
  • 7.2. Combined Oral Contraceptives
  • 7.3. Implanted Contraceptives
  • 7.4. Injected Contraceptives
  • 7.5. Intrauterine
  • 7.6. Oral Contraceptives
  • 7.7. Transdermal Patch
  • 7.8. Vaginal Ring

8. Hormonal Contraceptives Market, by End-user

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Gynecology Centers
  • 8.4. Homecare
  • 8.5. Hospitals & Clinics

9. Americas Hormonal Contraceptives Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Hormonal Contraceptives Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Hormonal Contraceptives Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Afaxys Pharma, LLC
  • 2. Agile Therapeutics
  • 3. Amgen Inc.
  • 4. Bayer AG
  • 5. Boehringer Ingelheim GmbH
  • 6. Cipla Limited
  • 7. Glenmark Pharmaceuticals Limited
  • 8. HLL Lifecare Limited
  • 9. Johnson & Johnson Services, Inc.
  • 10. Lupin Pharmaceuticals, Inc.
  • 11. Novartis AG
  • 12. Pfizer, Inc.
  • 13. Piramal Group
  • 14. Sun Pharmaceutical Industries Ltd.
  • 15. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. HORMONAL CONTRACEPTIVES MARKET RESEARCH PROCESS
  • FIGURE 2. HORMONAL CONTRACEPTIVES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. HORMONAL CONTRACEPTIVES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. HORMONAL CONTRACEPTIVES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HORMONAL CONTRACEPTIVES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HORMONAL CONTRACEPTIVES MARKET DYNAMICS
  • TABLE 7. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ANDROGENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ANTIANDROGENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ESTROGENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GONADOTROPINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY PROGESTOGENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTED CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTED CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY INTRAUTERINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GYNECOLOGY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 64. JAPAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 67. MALAYSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 70. PHILIPPINES HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 73. SINGAPORE HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 76. SOUTH KOREA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 79. TAIWAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 82. THAILAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 85. VIETNAM HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 92. DENMARK HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 95. EGYPT HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 98. FINLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 101. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 104. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 107. ISRAEL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 110. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 113. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 116. NIGERIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 119. NORWAY HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 122. POLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 125. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 128. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 131. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 137. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 140. SWEDEN HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 143. SWITZERLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 146. TURKEY HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. HORMONAL CONTRACEPTIVES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 154. HORMONAL CONTRACEPTIVES MARKET, FPNV POSITIONING MATRIX, 2023